Inotiv Announces November 2025 Investor Conference Lineup
Inotiv will hit the investor circuit in November, with management slated for one-on-one meetings at the UBS Global Healthcare...
No videos found.
Nurexone to Present at Cambridge’s Precision EV Forum
Nurexone Biologic will take the regulatory stage at the Precision EV Forum 2025 in Cambridge, UK, where its Director...
Rhythm Pharmaceuticals to Report Q3 2025 Financial Results
Rhythm Pharmaceuticals will report third-quarter 2025 results on November 4 and is lining up two investor discussions on November...
FDA’s 2025 Roadmap for Generics: Modernizing Policy, Transparency, and Global Alignment
At the Advancing Generics 2025 forum, FDA officials, policy leaders, and industry executives outlined the next phase of the...
Cytomed Makes Cash Bid for TC Biopharm Acquisition
Cytomed Therapeutics has submitted a cash bid to acquire selected assets of TC BioPharm, which entered administration on October...
Rezolute Announces Participation in Investor Conferences
Rezolute will hit the fall investor circuit with back-to-back appearances at the Maxim Growth Summit on October 22–23, the...
Teva, Prestige BioPharma in Tuznue® Deal for Europe
Teva has signed a license and supply agreement with Prestige Biopharma to commercialize Tuznue, a biosimilar to Herceptin (trastuzumab),...
Recordati Launches Prize for Paediatric Oncology Research
Recordati has launched the 12th Arrigo Recordati Prize with a 2026 focus on pediatric oncology, specifically sarcomas, offering a...
Lixte’s Q4 Focus: Advancing LB-100 & Oncology Growth
Lixte Biotechnology has set its fourth-quarter agenda and disclosed advanced negotiations to acquire complementary oncology assets, signaling a push...
Ligand Announcing Special Investor Day on December 9, 2025
Ligand Pharmaceuticals will host its annual Investor Day in New York on December 9, 2025, with management set to...